Not provided
Not provided
Not provided
Not provided
Not provided
Unavailable IT resources
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to assess the use of technology including remote vital sign monitoring in improving quality of patient care, decreasing hospital admissions and re-admissions, decreasing hospital length of stay and decreasing use of personal protective equipment.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| COVID-19 Patients | Experimental | Patients that are admitted to the hospital with COVID 19. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Doctorgram Patient Kit | Behavioral | Participants will use the Doctorgram Patient Kit for remote monitoring and remote use stethoscope. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patient provider experience survey score | Five questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 5 (higher scores = better experience). | Once after completion of device use (up to 15 minutes to complete the survey) |
| Provider experience survey score | Four questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 4 (higher scores = better experience). | Once after completion of device use (up to 15 minutes to complete the survey) |
| Use of personal protective improvement | Level of personal protective improvement in an in-patient setting. | 6 months |
| Number of in-patient encounters with COVID patients as a measure of provider exposure to high risk illness | 6 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ritu Parikh, MD | Stanford University | Principal Investigator |
| Julieta M Gabiola, MD | Stanford University | Principal Investigator |
| Nicholas Scoulios, MD | Stanford University | Principal Investigator |
| Lisa Shieh, MD | Stanford University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stanford University | Stanford | California | 94305 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |